Rankings
▼
Calendar
ALT FY 2015 Earnings — Altimmune, Inc. Revenue & Financial Results | Market Cap Arena
ALT
Altimmune, Inc.
$335M
FY 2015 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$11M
+4.4% YoY
Gross Profit
$6M
52.4% margin
Operating Income
-$3M
-32.0% margin
Net Income
-$3M
-32.3% margin
EPS (Diluted)
$-16.13
Cash Flow
Operating Cash Flow
-$3M
Free Cash Flow
-$3M
Stock-Based Comp.
$613,017
Balance Sheet
Total Assets
$20M
Total Liabilities
$3M
Stockholders' Equity
$17M
Cash & Equivalents
$16M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$11M
$10M
+4.4%
Gross Profit
$6M
$6M
-5.9%
Operating Income
-$3M
-$10M
+66.6%
Net Income
-$3M
-$10M
+65.4%
← FY 2014
All Quarters
Q4 2015 →